DR.MAX secures contract for Antineoplastic and Immunomodulating Agents - Framework Agreement Medications in the group; "Antineoplastic and immunomodulatory" - 2 lots - nivolumab

Romania, Oct. 7 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and Immunomodulating Agents - Framework Agreement Medications in the group; "Antineoplastic and immunomodulatory" - 2 lots - nivolumab. The value of the contract is worth 300300800 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....